William Smith, Phd Email & Phone Number

Affiliated with Boston-based think tank on policy issues related to life science companies.

Washington, Dc, Us

Managed an academic center and wrote scholarly articles and published a book.

Washington, Dc, Us

PhD Student and Doctoral Candidate

Washington, District Of Columbia, Us

Managed the healthcare practice of Washington, D.C. consulting firm and advised biotechnology, medical device and pharmaceutical companies about government affairs issues, organizational efficiency and issues management.

New York, New York, Us

Leader of policy, government relations, alliance development, medical advocacy and public affairs team to support Pfizer’s $23 billion U.S. commercial business. Member of the US Pharmaceutical Operations Leadership Team along with the five Regional Presidents/General Managers of Pfizer’s US commercial business units. Develop, lead and execute lobbying strategies on issues affecting Pfizer’s commercial business and the pharmaceutical industry in the U.S. Manage a multi-million dollar budget and a team of 58. Lead the company’s state government relations efforts in 50 states, including 26 field-based lobbyists, 45 contract lobbyists who represent Pfizer in 50 state capitals, the District of Columbia, and Puerto Rico. Manage a team of 6 Therapeutic Area leads who are embedded in the US business units to provide strategic policy support to the all aspects of the US commercial business. Manage a team of public affairs colleagues who develop and execute regional media strategies to support the U.S. commercial business and to navigate policy challenges across the country. Manage lobbying strategies on civil justice and tort reform issues and manage political relationships with state attorneys general. Manage a team of advocacy and professional relations professionals and their 40 consultants who build strategic relationships around the US including patient advocates, multicultural groups, business groups, medical societies, unions, biotech associations, and legislative organizations. Direct company grass roots programs in 50 states. Support U.S. site leaders by developing and executing community relations strategies to deal with site closures, expansions, philanthropic donations, corporate tax issues and community interactions, e.g. the ongoing closure of the huge laboratory complex in Ann Arbor, MI. Direct company grass roots programs in 50 states. Member of the Board of Directors for Pfizer Helpful Answers, Pfizer’s philanthropic program.

New York, New York, Us

Represented Pfizer in four New England states. Lobbied on some of the most difficult issues faced by the industry including drug importation, bulk purchasing, price controls, marketing restrictions, and investment divestiture. Created and led a new government relations strategy built around media relations. Provided community relations support to Pfizer’s Cambridge site, one of the most important R&D sites in the Pfizer inventory.

Advised the Governor and senior state officials on all policy matters and strategic decisions relating to the federal government and the federal Congress. Chief lobbyist for the state with federal officials, Members of Congress, and their staffs. Provided policy guidance and strategic advice on all interstate relations. Primary point of contact in the Governor’s office for the Massachusetts congressional delegation. Represented the Governor and provided policy guidance at national and regional governor’s organizations including the National Governors’ Association (NGA), the Republican Governors’ Association (RGA), the Coalition of Northeast Governors (CONEG), and the New England Governors’ Conference (NEGC). Served the Vice-Chairman of the Staff Advisory boards of CONEG. Point of contact for governors’ offices from other states. Helped develop and execute the strategy to secure federal funding for state highway programs (including the Central Artery Project, a.k.a. “The Big Dig”), federal loan guarantees for Massachusetts’ companies, defense contracts, etc. Served as Policy Director for Gov. Paul Cellucci’s transition team, conceived of strategic plan for policy development in advance of his inauguration; oversaw establishment and activities of four working groups composed of senior private sector leaders and academics charged with analyzing and recommending broad policy guidelines for the new administration; wrote final transition team policy report for Governor.

Advised the Governor and senior state officials on all policy matters and strategic decisions relating to the federal government and the federal Congress. Chief lobbyist for the state with federal officials, Members of Congress, and their staffs. Provided policy guidance and strategic advice on all interstate relations. Primary point of contact in the Governor’s office for the Massachusetts congressional delegation. Represented the Governor and provided policy guidance at national and regional governor’s organizations including the National Governors’ Association (NGA), the Republican Governors’ Association (RGA), the Coalition of Northeast Governors (CONEG), and the New England Governors’ Conference (NEGC). Served the Vice-Chairman of the Staff Advisory boards of CONEG. Point of contact for governors’ offices from other states. Helped develop and execute the strategy to secure federal funding for state highway programs (including the Central Artery Project, a.k.a. “The Big Dig”), federal loan guarantees for Massachusetts’ companies, defense contracts, etc. Served as Policy Director for Gov. Paul Cellucci’s transition team, conceived of strategic plan for policy development in advance of his inauguration; oversaw establishment and activities of four working groups composed of senior private sector leaders and academics charged with analyzing and recommending broad policy guidelines for the new administration; wrote final transition team policy report for Governor.

Primary advisor to the Governor’s office during the 1995 federal base closure process. Primary state official interacting with the communities impacted by base closures. Developed and presented case for Hanscom and other military bases in Massachusetts to senior Pentagon officials, Members of Congress, and the defense Base Closure and Realignment Commission. Managed Washington D.C. consultants retained by the state to assist in preventing base closures. Commissioned and supervised MIT study demonstrating military value of Hanscom AFB. State spokesman on base closure issues. Liaison to military installations throughout the Commonwealth. Central responsibility was to preserve Hanscom Air Force Base in Bedford, Mass., which is not only the state’s largest military facility but also a leading state employer and the largest purchaser of military electronics and R&D.

Principal aide to the Director. Principal advisor on policy, personnel, and administrative issues. Coordinated and directed ONDCP components offices in order to develop the President’s National Drug Control Strategy. Policy areas included international narcotics control, drug interdiction, law enforcement, drug treatment, and drug education. Senior policy reviewer of President George H. W. Bush’s speeches and remarks related to drug policy. Managed day-to-day operations of ONDCP, a $20 million White House office with staff of 120. Managed congressional relations staff. Accompanied director on domestic and international travel and represented the United States abroad including service as the principal U.S. government negotiator on U.S./Spain Demand Reduction Agreement. Principal point of contact for White House Situations Room in the event of a national security emergency related to narcotics trafficking.Security Clearance: Top Secret/SCI

Senior policy advisor to the Director. Oversaw and coordinated projects and initiatives or ONDCP component offices. Coordinated the development and implementation of the President’s drug policies with senior officials from federal agencies. Developed communications plans; managed the office of public affairs, including press secretary and assistant press secretaries; generated media coverage of drug policies issues; wrote Director’s major speeches and op-eds. Resolved personnel issues. Assisted in the management of ONDCP operations. Security Clearance: Top Secret/SCI

Chief Republican staff aide for the Committee. Senior advisor to House Republican leadership on federal drug policy. Briefed Members of Congress and developed legislative initiatives for House Republicans. Senior House Republican staffer coordinating the introduction of President Bush’s 1990 Comprehensive Crime Control Act into the House of Representatives. Prepared Committee hearings and reports. Conducted investigations and oversight of Federal anti-narcotics programs. Supervised Republican professional and support staff, including press secretary. Participated in weekly Senior Staff strategy meetings with House Republican Leader Robert MichelSecurity Clearance: Top Secret

Represented the President’s anti-drug policies to the U.S. House of Representatives, the U.S. Senate, and their staff. Negotiated the details of drug-related legislation. Wrote testimony and prepared the Director and senior ONDCP staff for congressional hearings. Formed legislative initiatives related to the President’s National Drug Control Strategy.Security Clearance: Secret

Ma, Political Philosophy

International Narcotics Trafficking

Ba, History

Doctor Of Philosophy (Phd), Political Science And Government

Phd, With Distinction, Political Philosophy

Phd, With Distinction, Political Philosophy

Doctor Of Philosophy (Phd) With Distinction, Political Philosophy

Phd, With Distinction, Political Science And Government